Peyrin-Biroulet L, Allegretti JR, Rubin DT, Bressler B, et al. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study. Gastroenterology 2023 Aug 31:S0016-5085(23)04963.
PMID: 37659673